Akademik Veri Yönetim Sistemi
Ophthalmic Plastic and Reconstructive Surgery, cilt.39, sa.2, ss.174-181, 2023 (SCI-Expanded)
Purpose: To evaluate meibomian gland and subbasal nerve plexus parameters in Graves' Ophthalmopathy (GO) and association of meibomian gland loss with corneal subbasal nerve plexus loss. Methods: Fifty-two eyes of 52 mild and moderate-to-severe GO patients and 32 eyes of 32 healthy controls were enrolled. The meibomian gland dropout area (MGDA) and meibography scores were evaluated using noncontact meibography. In vivo confocal microscopy of corneal subbasal nerve plexus were conducted. ACCMetrics was used to obtain corneal parameters. Results: Compared with healthy subjects, GO patients had worse upper and lower eyelid MGDA (p < 0.001, for all) and upper, lower and total meibography scores (p < 0.001, p = 0.001, and p < 0.001, respectively). Eyelid margin scores were worse in the GO group (p < 0.001) and showed correlation with all noncontact meibography parameters (p < 0.001 for all). All corneal subbasal nerve parameters were significantly lower in the GO group compared with the controls (p < 0.05 for all). Subbasal nerve parameters of GO patients did not reveal a correlation with MGDA and meibography scores but showed correlations with ocular surface disease index score and Schirmer I test (r = -0.304; p = 0.042 and r = 0.336; p = 0.021, respectively). Conclusion: Meibomian gland and corneal nerve loss could be observed even in the inactive phase and mild GO. The lack of a correlation between meibomian gland loss and subbasal nerve loss suggests that meibomian gland loss is not a significant additional component in the pathogenesis of subbasal nerve damage in GO. Furthermore, our study revealed new evidence regarding the use of eyelid margin score to represent meibomian gland loss in GO.